Head-to-head · WeighScore
EdgeRx vs Lyfe Rx
By GLP-1 ScorecardUpdated
Score comparison
EdgeRx has the higher recorded score — 79/100 to 55.9/100.
EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EdgeRx lists compounded GLP-1 injections in a men’s health program. Its terms say the final charge can vary with the prescription and pharmacy.
Before you choose
Lyfe Rx does not publish a semaglutide price, so its Lyfe Rx review sets out what it does disclose, while the EdgeRx review explains the conditions attached to EdgeRx's figure. The semaglutide cost page compares published rates across the field. Ask Lyfe Rx for a written total before treating either one as the cheaper choice.
If neither one fits, EdgeRx vs Next Vial and Enhance MD vs Lyfe Rx compare each of them with another graded program, and the list of alternatives to EdgeRx ranks the programs closest to EdgeRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | EdgeRx | Lyfe Rx |
|---|---|---|
| WeighScore | 79/100 | 55.9/100 |
| Grade | C+ | C |
| Site position | #42 | #460 |
| Semaglutide | Advertised $199/mo; confirm final prescription charge | Confirm selected order price |
| Tirzepatide | Advertised $225/mo; confirm final prescription charge | Confirm selected order price |
| Coverage | 47 states advertised; excludes Arkansas, Indiana and South Carolina | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes separate semaglutide and tirzepatide prices
- Names Strive as its primary 503A pharmacy in its terms
- Advertises included shipping and physician review
What to consider
- The final charge may vary with the prescribed product and dispensing pharmacy
- The homepage’s approval refund language needs to be reconciled with the consultation fee and final-sale terms
FDAWarning letter issued to Lyfe Rx in September 2025. See the FDA warning-letter database.
Strengths
- Advertises a one-month order option
- Publishes a care guide explaining who reviews and fills an order
What to consider
- Care guide says placed orders cannot be canceled
- A clinical review fee can be retained if treatment is declined
- FDA issued Lyfe Rx a warning letter in September 2025
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.